MedTrace Logo

A Danish Nationwide Longitudinal Study on Prevalence of Periodontitis and Its Co-morbidities

NCT05574231 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000000

Last updated 2022-10-10

No results posted yet for this study

Summary

The project (PlanPerioMed) is a register-based study evaluating the associations and patterns of health care delivery between periodontitis and medical diseases using data from the Danish dental record system Dentalsuite (Plandent A/S) and national Danish health care registries with three overall hypotheses/ aims:

* Determine the extent to which periodontitis in registry data is associated with more odontological treatment services and treatment frequency.
* Determine if patients with systemic diseases attend dentists more frequently and receive more treatment services per patient than the population without these diseases.
* Determine to which extent periodontitis and received periodontal treatment affects the risk of medical diseases.

The study will focus on association and trajectories of periodontitis and its treatment with three medical diseases, namely, Type 2 Diabetes Mellitus (Type 2 DM), Cardiovascular Diseases (CVD) and Rheumatoid Arthritis (RA). The dataset consists of approximately 4,000,000 people aged between 18 and 99 years attending private practice in Denmark. The results from PlanPerioMed study are likely to have ramifications for treatment guidelines for other periodontitis comorbidities, e.g. CVD and DM, and will thereby improve the quality of life for a wide range of patients and reduce long-term societal health care expenses related to periodontitis and its comorbidities.

Conditions

Interventions

PROCEDURE

Periodontal treatment

It includes surgical and non-surgical procedures depending on patient as well as tooth level.

Sponsors & Collaborators

  • Plandent A/S

    collaborator UNKNOWN

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Anne Havemose Poulsen · Head of Department

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05574231 on ClinicalTrials.gov